Jacob Chacko, PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 125,000 shares at $10.80 ($1.4M) on 2025-09-22, disclosed to the SEC on 2025-09-24.
Scheduled sale ($1.4M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |
| ORIC | SELL | 2024-03-08 | $648K | — | Filing → |